Literature DB >> 22775991

Review of ethnic disparities in access to renal transplantation.

Shivam Joshi1, Jeffrey J Gaynor, Gaetano Ciancio.   

Abstract

Renal transplantation is the gold standard treatment for patients with end-stage renal disease and is associated with several advantages over dialysis, including increased quality of life, reduced morbidity and mortality, and lower healthcare costs. Barring the constraints of a limited organ supply, the goals of the patient care should focus on attaining renal transplantation while minimizing, or even eliminating, time spent on dialysis. Disparities in access to renal transplantation between African Americans and Caucasians have been extensively documented, with African Americans having significantly poorer access. There is a growing corpus of literature examining the determinants of reduced access among other racial ethnic minority groups, including Hispanics. These determinants include patient and physician preference, socioeconomic status, insurance type, patient education, and immunologic factors. We review these determinants in access to renal transplantation in the United States among all races and ethnicities.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22775991     DOI: 10.1111/j.1399-0012.2012.01679.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  9 in total

1.  Do racial and ethnic disparities in health care use vary with health?

Authors:  Adam I Biener; Samuel H Zuvekas
Journal:  Health Serv Res       Date:  2018-11-14       Impact factor: 3.402

2.  Differences in Physicians' Verbal and Nonverbal Communication With Black and White Patients at the End of Life.

Authors:  Andrea M Elliott; Stewart C Alexander; Craig A Mescher; Deepika Mohan; Amber E Barnato
Journal:  J Pain Symptom Manage       Date:  2015-08-20       Impact factor: 3.612

3.  The Combined Roles of Race/Ethnicity and Substance Use in Predicting Likelihood of Kidney Transplantation.

Authors:  Richelle N DeBlasio; Larissa Myaskovsky; Andrea F DiMartini; Emilee Croswell; Donna M Posluszny; Chethan Puttarajappa; Galen E Switzer; Ron Shapiro; Annette J DeVito Dabbs; Amit D Tevar; Sundaram Hariharan; Mary Amanda Dew
Journal:  Transplantation       Date:  2022-04-01       Impact factor: 5.385

4.  Impact of age, race and ethnicity on dialysis patient survival and kidney transplantation disparities.

Authors:  Connie M Rhee; Paungpaga Lertdumrongluk; Elani Streja; Jongha Park; Hamid Moradi; Wei Ling Lau; Keith C Norris; Allen R Nissenson; Alpesh N Amin; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2014-02-15       Impact factor: 3.754

5.  Public trust in genomic risk assessment for type 2 diabetes mellitus.

Authors:  Rachel Mills; William Barry; Susanne B Haga
Journal:  J Genet Couns       Date:  2013-12-03       Impact factor: 2.537

6.  Influence of Socio-Economic Inequalities on Access to Renal Transplantation and Survival of Patients with End-Stage Renal Disease.

Authors:  Wahida Kihal-Talantikite; Cécile Vigneau; Séverine Deguen; Muriel Siebert; Cécile Couchoud; Sahar Bayat
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

7.  Inequalities and outcomes: end stage kidney disease in ethnic minorities.

Authors:  Emma Wilkinson; Alison Brettle; Muhammad Waqar; Gurch Randhawa
Journal:  BMC Nephrol       Date:  2019-06-26       Impact factor: 2.388

8.  Barriers to Accessing Kidney Transplantation Among Populations Marginalized by Race and Ethnicity in Canada: A Scoping Review Part 1-Indigenous Communities in Canada.

Authors:  Noor El-Dassouki; Dorothy Wong; Deanna M Toews; Jagbir Gill; Beth Edwards; Ani Orchanian-Cheff; Mary Smith; Paula Neves; Lydia-Joi Marshall; Istvan Mucsi
Journal:  Can J Kidney Health Dis       Date:  2021-03-03

9.  Disparities in pulmonary fibrosis care in the United States: an analysis from the Nationwide Inpatient Sample.

Authors:  Adam W Gaffney; Steffie Woolhander; David Himmelstein; Danny McCormick
Journal:  BMC Health Serv Res       Date:  2018-08-08       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.